Furthermore, several studies are reporting that activating S1PR2 promotes hepatic fibrosis (Yang et al., 2015), portal hypertension (Kageyama et al., 2012), BECs proliferation and liver injury in the animal models of cholestasis (Wang et al., 2017). The gene discussed is S1PR2; the disease is portal hypertension.